camcevi
accord healthcare s.l.u. - leuprorelin mesilate - prostatetické novotvary - endokrinní terapie - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.
scemblix
novartis europharm limited - asciminib hydrochloride - leukemie, myelogenní, chronická, bcr-abl pozitivní - antineoplastická činidla - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.
akeega
janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prostaty, nádorů, kastrace-odolné - antineoplastická činidla - treatment of adult patients with prostate cancer.
abirateron aristo 250mg tableta
aristo pharma gmbh, berlin array - 19572 abirateron-acetÁt - tableta - 250mg - abirateron
abirateron aristo 500mg potahovaná tableta
aristo pharma gmbh, berlin array - 19572 abirateron-acetÁt - potahovaná tableta - 500mg - abirateron
abiraterone glenmark 500mg potahovaná tableta
glenmark pharmaceuticals s.r.o., praha array - 19572 abirateron-acetÁt - potahovaná tableta - 500mg - abirateron
abiraterone g.l. pharma 250mg tableta
g.l. pharma gmbh, lannach rakousko - 19572 abirateron-acetÁt - tableta - 250mg - abirateron
abiraterone g.l. pharma 500mg potahovaná tableta
g.l. pharma gmbh, lannach array - 19572 abirateron-acetÁt - potahovaná tableta - 500mg - abirateron
abiraterone heaton 250mg tableta
heaton k.s., praha array - 19572 abirateron-acetÁt - tableta - 250mg - abirateron
abiraterone heaton 500mg potahovaná tableta
heaton k.s., praha array - 19572 abirateron-acetÁt - potahovaná tableta - 500mg - abirateron